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Purpose: The purpose of the current research was to detect the underlying genetic defect in a Chinese family with X-
linked congenital nystagmus and perform prenatal genetic diagnosis for their current pregnancy.
Methods: A common clinical examination and an ophthalmic evaluation were performed on the proband, one carrier, and
one unaffected member. Mutation analysis of the G protein-coupled receptor 143 (GPR143) and four-point-one (4.1),
ezrin, radixin, moesin (FERM) domain-containing 7 (FRMD7) genes was performed by direct sequencing of PCR-
amplified exons in the proband. The detected GPR143 mutation was tested in all available family members and 200 normal
controls by direct sequencing.
Results: Congenital nystagmus, obvious fundus hypopigmentation, and foveal hypoplasia were observed in the proband
but not in the carriers or the unaffected members. A novel splicing mutation c.658+1 g>t not found in 200 unrelated
controls was identified and co-segregated with X-linked ocular albinism (XLOA) in this family. The fetus (V:5) was
hemizygous for this mutant allele.
Conclusions: We identified a novel causative mutation of GPR143 in a five-generation Chinese family with XLOA. This
expanded the mutation spectrum of GPR143 and provided data elucidating the diverse and variable effects of GPR143
mutations.
Congenital nystagmus (CN) is a common oculomotor
disorder with a frequency of 1/20,000 live births [1]. It is
characterized  by  involuntary,  rhythmical,  repeated
oscillations of one or both eyes with onset typically at birth or
within the first few months of life. Patients’ oscillations can
be horizontal, vertical, torsional, or any combination of these,
although horizontal is the most common [2].
CN is genetically heterogeneous. Two genes responsible
for X-linked CN have been identified (i.e., G protein-coupled
receptor 143 (GPR143) for X-linked ocular albinism
(XLOA)  [3]  and  four-point-one  (4.1),  ezrin,  radixin,
moesin (FERM) domain-containing 7 (FRMD7) for X-linked
CN-1 [4,5]). The third X-linked form of CN has been mapped
to Xp11.4-p11.3 [6].
Here, we report on a five-generation Chinese family with
X-linked CN. Mutation analysis of the two candidate genes
(FRMD7  and  GPR143)  indicated  that  a  novel  splicing
mutation of GPR143 was responsible for the disease in this
family.
METHODS
Patients: The CN family studied here came from the Hunan
province in the southern part of China and comprised five
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generations  with  nine  affected  members  (Figure  1).  The
proband (V:4) was referred to our clinic at the age of seven
because of his horizontal CN in both eyes. After an uneventful
38-week pregnancy of the primigravid mother, he was born at
a normal weight. Consanguinity was denied, and no chemical
exposure or maternal drug use was noted during his mother’s
pregnancy. This study complied fully with the Tenets of the
Declaration of Helsinki, and it was approved by the Ethics
Board of the State Key Laboratory of Medical Genetics of
China. Informed consent was given by all members of the
family before testing.
Mutation screening: Genomic DNA was extracted from the
peripheral  blood  using  the  standard  phenol/chloroform
method and stored at −20 °C. Mutation analysis of GPR143
and FRMD7 was performed using polymerase chain reaction
(PCR) and direct sequencing. Primers were designed to cover
the sequences of all exons and introns adjacent to each exon
of  GPR143  and  FRMD7,  according  to  published  primer
sequences  (Table  1)  [7,8].  PCR  products  were  directly
sequenced with an ABI PRISM BigDye kit (Carsbad, CA)
using the same ampliﬁcation primers on an ABI3100 DNA
sequencer (Carsbad, CA). Sequences were analyzed with the
DNASTAR (Madison, WI) software.
A  total  of  200  healthy,  unrelated  volunteers  were
recruited as controls, including 103 males and 97 females aged
10–60 years with an average age of 33. The novel splicing
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715mutation of GPR143 was tested in the 200 healthy controls by
direct sequencing.
RESULTS
Clinical findings: Nine males in three successive generations
of the Chinese family were affected, indicating that the disease
may be inherited in an X-linked recessive pattern in this family
(Figure 1). The proband presented with typical symptoms of
CN, including nystagmus, amblyopia, foveal hypoplasia, and
fundus hypopigmentation. Results of a computed tomography
(CT) scan of the brain were normal in the proband.
Nystagmus  and  reduced  visual  acuity—The  nine
patients all had nystagmus and poor visual acuity as a first
symptom. The nystagmus was present during their first three
months of life with a corrected visual acuity (VA) of 0.1–0.2.
The proband’s (V:4) nystagmus was sometimes associated
with head nodding, and the amplitude varied with horizontal
gaze position. In all patients, the nystagmus had a tendency to
diminish with age, while it rarely disappeared completely
(e.g.,  the  proband’s  grandfather  (III:5)  continued  to
experience nystagmus even at age 60). The proband’s mother
(IV:9), a carrier, did not experience nystagmus, and her VA
was normal.
Fundus hypopigmentation and foveal hypoplasia—In
the present study, fundus examinations were performed in
most patients, carriers, and unaffected members of the family
(Table 2). Significant hypopigmentation of the ocular fundus
periphery  with  normal  pigmentation  of  skin  and  hair  and
foveal hypoplasia were observed in the proband (Figure 2A),
while his mother (Figure 2B) and his uncle (Figure 2C) did
not exhibit such symptoms.
Iris hypopigmentation—Compared with an unaffected
member (Figure 3C), the proband exhibited mild peripheral
iris hypopigmentation, as shown in Figure 3A. As a carrier,
his mother did not show peripheral iris hypopigmentation
(Figure 3B).
Mutation screening: The nine patients and the fetus (V:5)
were hemizygous for a novel splicing mutation c.658+1G>T
(Figure  4A,C),  while  carriers  were  heterozygous  for  this
genotype (Figure 4B) and unaffected members were normal
(Figure  4D).  The  splicing  mutation  c.658+1G>T  was  not
found in the 200 unrelated controls.
DISCUSSION
In 1995, Schiaffino et al. [3] screened the entire GPR143
coding sequence and detected various mutations in one-third
TABLE 1. PRIMERS AND PCR CONDITIONS USED TO AMPLIFY GENOMIC SEGMENTS OF GPR143 AND FRMD7.
Primer name Forward primer(5’-3’) Reverse primer(5’-3’) Annealing
temperature
(°C)
Product
size (bp)
GPR143-1a CTCCTCCGCCCGCCCAAGCATCAC CCCAGGCAGCCGAGAAGGTC 66 464
GPR143-1b CCGCGCCTAGGGACCTTCTGCT AACCCGCGGGCCTCTCGTCCTCAC 69 399
GPR143-2 CTTTCTTCCTTTTCCCTCCTTGTC GTTTGCTGCTGCTGCGATTTG 61 360
GPR143-3 CACGTGCGGCTTCCTGAC TTGGCCTCTTATAAAAATGA 59 385
GPR143-4 GGGCTTTCCTCTGTGTACATTTTC CCCTGAGACAACGGCCTAACC 63 334
GPR143-5 GCATTTCCCTTTTTGTTCTCATCC AGGCCTGCACATTTTCATTTATTG 61 406
GPR143-6 TTGCTTCCTGCCCCTCTGG ACTTGCTCCCCTGTCCTCTGT 63 400
GPR143-7 TGCACCTGGCCCTCTTAGTTTC TCAGGAGGCCAAGACAGAGGAT 63 441
GPR143-8a AAACCAACCCACCAACCAGTCAAC GCATGCTCAGGGCTTCGTCA 63 395
GPR143-8b CCAGCCCAGGGATTTCTCTT ACCCCGCCATGCACAGGAC 63 329
GPR143-9 AGCTGATGACAAACCTGCTAG CCCTTTCTCCTATCCTAAAG 61 330
FRMD7-1 CCTTGGGTGTGCATTACTTC TTTGCTATTGTTGTCCCTTGAG 57 459
FRMD7-2 AAACAACACAGAGACAGATAAGTGG CAATCAGGGAATTGAACCCTAC 57 385
FRMD7-3 AGGCAGTGGAGCAGTGATTC GCAGCATGATTTCTTTCATCTC 68 499
FRMD7-4 CTCGAAGGCAGAGAGGGTAG CCCTTTGGATGATGAACACC 69 519
FRMD7-5 GGCACCATTCCTTTCTTGAAT CAGGCCATGCTGTTTCTCTC 57 350
FRMD7-6 TTTGGACTGCATTGGCTACA AGGATCTCAGCGTTTCATGG 57 353
FRMD7-7 TCATGCACTTTCATCAGAAGC TGATTGACCATTTCCCTTTC 57 497
FRMD7-8 TGTGCAAGAGATGGGTCAAG CTCTGGTTGATTTCTTCAAAGG 57 368
FRMD7-9 GCTCTGTTTGTGAGCAGTGG AGGGTGCAATCTTTGATGTG 57 495
FRMD7-10 AGGTTGTTCTCTGCCTGGTC GCACTGTCGTTCATGGTACTG 57 398
FRMD7-11 TGTTTCTCTTGCTCGTGTTGA TTTTTACACACTGGGATTCTGG 57 282
FRMD7-12a CCCTAGAATAGAACATGGATCTTG TGGGATCAGGGTTAGGATTG 57 388
FRMD7-12b CCTTCTTTCACCAATGTGTCC AATACCAACCTGCTGACCTG 57 452
FRMD7-12c CTTTAACACTGAGCCCAATC TGACTGAGAGCAGGACAAGG 57 588
FRMD7-12d ACGGATGTGCCCTATATTCC GCAACTCCTGCTCTGCAAAC 57 472
FRMD7-12e AGCCCAAGGAATATCAGAATG GCAGTTGGTGTGTTGAAATAAGC 57 500
FRMD7-12f GCTCTCAGTCATAAAGCAGACC CCTTCAGAGGTAATGGAAGAGTG 57 500
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716of XLOA patients. To date, more than 99 different mutations
of GPR143, involved in most exons, have been published
[9]. Prior to 2007, XLOA in the Chinese population was
infrequently reported [2], and to date, only 11 mutations of
GPR143  have  been  described  in  the  Chinese  population
including 3 missense mutations [2,7,10], 1 splicing mutation
[7], 6 deletion mutations [7,11,12], and 1 duplication mutation
[13]. The 11 mutations were all associated with nystagmus but
without ocular albinism (OA). In the present study, the novel
mutations of c.658+1G>T were found to cause CN in a large
Chinese  family.  The  cumulated  number  and  ethnic
distribution of known mutations will help further study in the
pathogenesis of CN.
GPR143 on chromosome Xp22.3 contains nine exons and
encodes  a  protein  of  404  amino  acids  containing  seven
putative  transmembrane  domains  and  one  potential  N-
glycosylation site using an asparagine at codon 106 [14].
GPR143 is mainly expressed in skin and retinal pigmented
epithelial cells. The GPR143 protein is a G protein-coupled
receptor  (GPCR)  that  is  embedded  in  the  melanosome
membrane [15], with the NH2-terminus of the protein in the
melanosome lumen and the COOH-terminus in the cytosol.
In the present study, we found a splice site mutation of
GPR143 at the exon-intron 5 boundary (c.658+1G>T) and in
the 5′ consensus donor region for the splicing of intron 5–6.
This mutation may lead to two possible effects: the loss of the
original splicing donor or the generation of a new splice site.
If  the  original  splicing  donor  disappears,  the  exon  5  of
GPR143 may be lost, thus leading to the introduction of a stop
codon. This creates a truncated protein of 187 amino acids
(Figure 5), which is much shorter than the normal full-length
protein of 404 amino acids, and it may seriously affect the
function of this protein. On the other hand, we searched for
potential abnormal splice sites generated by this mutation
using NNSPLICE software [16] and found some possible
displaced  splice  sites.  Being  used  instead  of  the  missing
original splice site, the neighboring cryptic splice sites might
result in short, erratic sequences ending with a stop codon after
the  normal  sequence.  If  the  abnormal  mRNA  is  actually
translated and escapes degradation, the encoded protein will
be truncated and dysfunctional.
XLOA, a disorder of melanosome biogenesis leading to
congenital and persistent visual impairment in affected males,
is  characterized  by  CN,  reduced  visual  acuity,
Figure 1. The Chinese CN pedigree. Black-filled symbols indicate patients who carried the novel mutation in the hemizygous state. Dot-
marked symbols represent females who carried the mutation. The proband is marked by arrow.
TABLE 2. SUMMARY OF CLINICAL FEATURES OF SOME AFFECTED MALES AND CARRIERS.
ID#
patients
Gender Iris hypopigmentation Albinotic
fundus
Fundus hypopigmentation Fundus foveal
hypoplasia
Nystagmus
V:4 Male Mild No Obvious Obvious Yes
III:5 Male Mild No Obvious Obvious Yes
III:7 Male Mild No Obvious Obvious Yes
III:9 Male Mild No Obvious Obvious Yes
III:17 Male Mild No Mild Obvious Yes
IV:17 Male Obvious No Obvious Obvious Yes
Carriers
IV:9 Female Normal No Normal No No
III:12 Female Normal No Normal No No
II:5 Female Normal No Normal No No
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717hypopigmentation  of  the  iris  pigment  epithelium  and  the
ocular fundus, and foveal hypoplasia [17]. XLOA is a non-
progressive  disorder,  and  visual  acuity  remains  stable
throughout  life.  Nystagmus  has  been  reported  in  ocular
albinism patients with mutations of GPR143 and is thought to
be a secondary phenotype in these patients [18]. However, one
of the classical OA phenotypes, ocular albinism, has rarely
been observed in patients with GPR143 mutations. Fang et al.
[7] found a similar splicing mutation c.658+1G>A in a family
with XLOA; however, the patients’ phenotypes differed from
those of our patients. While fundus hypopigmentation existed
in  our  proband  but  not  in  theirs,  both  showed  mild  iris
hypopigmentation.  On  the  contrary,  fundus
hypopigmentation appeared in their carriers but not in ours. It
Figure 2. Fundi photographs. A: Fundus of the proband (V4) revealed severe fundus hypopigmentation (blue arrow) and foveal hypoplasia
(white arrow). B: The fundus of the carrier mother (IV9). C: Normal fundus (IV10).
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718Figure 3. Iris photographs. A: Irises of the proband (V4) revealed mild hypopigmentation (blue arrow). B: Irises of the carrier mother (IV9).
C: Normal irises of an unaffected member (IV10).
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719Figure 4. Sequencing of GPR143. A: Sequence in the proband (V4) showing a novel splicing mutation c.658+1G>T. B: Sequence in the
proband's mother (IV9) revealing a heterozygous mutation. C: The sequencing result of the fetus (V5) hemizygous for the mutant allele. D:
Sequence in an unaffected male member (III6) hemizygous for the wild type allele.
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720is still unclear why these two mutations at the same locus (c.
658+1G>T  and  c.658+1G>A)  in  GPR143  cause  different
phenotypes. It is possible that the new splice site generated by
these two mutations will result in the expression of part intron
in the 5′ consensus donor region for the splicing of intron 5–
6. Thus, the mutation c.658+1G>T will introduce a new amino
acid p.220Val, while c.658+1G>A will introduce p.220Asp.
Different amino acids may lead to different protein structures
and eventually produce different phenotypes.
The role of GPR143 in the development of the visual
system is currently poorly understood [19]. In the present
study, we identified a novel causative mutation of GPR143
and offered a reliable prenatal genetic diagnosis in a five-
generation Chinese family with XLOA. Our findings both
expand the mutation spectrum of GPR143 and provide data
elucidating  the  diverse  and  variable  effects  of  GPR143
mutations.
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